SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.530
+0.060 (1.73%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
SAB Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 248 | 178 | 35 | 63 | 30 | 340 | |
| Market Cap Growth | 2071.26% | 408.46% | -44.79% | 113.36% | -91.25% | - | |
| Enterprise Value | 157 | 73 | 9 | 66 | 27 | 336 | |
| Last Close Price | 3.53 | 3.74 | 3.79 | 6.88 | 5.90 | 78.10 | |
| PE Ratio | - | 41.78 | - | - | - | - | |
| PS Ratio | - | - | 26.48 | 28.33 | 1.24 | 5.58 | |
| PB Ratio | 1.11 | 1.18 | 1.35 | 1.11 | 0.96 | 8.81 | |
| P/TBV Ratio | 1.64 | 1.18 | 1.35 | 1.11 | 0.96 | 8.81 | |
| P/OCF Ratio | - | - | - | - | - | 170.89 | |
| EV/Sales Ratio | - | - | 6.91 | 29.32 | 1.14 | 5.51 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.18 | 0.10 | 0.19 | 0.22 | |
| Net Debt / Equity Ratio | -0.60 | -0.60 | -0.62 | -0.88 | -0.29 | -0.64 | |
| Net Debt / EBITDA Ratio | 1.98 | 1.98 | 0.42 | 1.48 | 0.36 | 2.07 | |
| Net Debt / FCF Ratio | 1.98 | 1.98 | 0.47 | 2.00 | 0.36 | 2.76 | |
| Asset Turnover | - | - | 0.02 | 0.03 | 0.36 | 0.88 | |
| Quick Ratio | 9.13 | 9.13 | 2.61 | 5.23 | 1.37 | 1.56 | |
| Current Ratio | 9.46 | 9.46 | 2.98 | 5.45 | 1.47 | 1.90 | |
| Return on Equity (ROE) | 14.96% | 14.96% | -81.92% | -95.51% | -53.85% | -44.21% | |
| Return on Assets (ROA) | -28.20% | -28.20% | -41.86% | -35.30% | -27.37% | -12.16% | |
| Return on Capital Employed (ROCE) | -30.20% | -30.20% | -118.50% | -52.10% | -80.50% | -24.50% | |
| Earnings Yield | 1.72% | 7.46% | -97.39% | -66.52% | -63.04% | -5.05% | |
| FCF Yield | -18.43% | -25.67% | -98.89% | -39.91% | -86.20% | -2.64% | |
| Buyback Yield / Dilution | -562.28% | -562.28% | -67.74% | -26.86% | -59.20% | -1.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.